The experiences related by these women are heartbreaking. They also echo allegation’s put forth by thousands of others, including our Firm’s own vaginal mesh lawsuit clients.
New York, New York (PRWEB) May 05, 2014
As Johnson & Johnson continues to face a growing number of transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) involving products marketed by its Ethicon, Inc. unit, Bernstein Liebhard LLP notes that a number of women allegedly harmed by these pelvic mesh devices staged a protest at the company’s latest shareholder meeting. According to a report published by the Associated Press on April 25th, a least one woman directly addressed the company’s CEO during the meeting, telling him that Ethicon transvaginal mesh devices had caused her and tens of thousands of others to "suffer lifelong, disabling pain." *
A number of other women related their experiences with transvaginal mesh during the press conference held just prior to the meeting. According to the Associated Press, they too described a wide range of vaginal mesh complications that were allegedly caused by Ethicon mesh products used to treat pelvic organ prolapse and stress urinary incontinence. They also called on Johnson & Johnson to take responsibility for their alleged suffering.
“The experiences related by these women are heartbreaking. They also echo allegation’s put forth by thousands of others, including our Firm’s own vaginal mesh lawsuit clients,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to evaluate vaginal mesh lawsuits on behalf of women who suffered serious injuries allegedly due to products marketed by Ethicon and other manufacturers.
Transvaginal Mesh Lawsuits
Court documents indicate that more than 1,700 vaginal mesh lawsuits have been filed against Johnson & Johnson and Ethicon in a federal multidistrict litigation underway in U.S. District Court, Southern District of West Virginia. Jeffrey S. Grand, a partner with Bernstein Liebhard LLP, is currently serving on the Plaintiff’s Steering Committee in this proceeding. All of the lawsuits filed in the litigation claim the companies’ pelvic mesh devices caused painful and debilitating vaginal mesh complications in tens of thousands of women. (In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2327)
Mr. Grand is also serving as Co-Liaison Counsel in a multicounty litigation now underway in New Jersey Superior Court for transvaginal mesh lawsuits filed against Ethicon and Johnson & Johnson. He was also a member of the Plaintiff’s trial team on the first Ethicon trial in that proceeding, which ended in March 2013 with a jury awarding $11 million in compensatory and punitive damages to a woman who was harmed by the Ethicon Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10)
In addition to his work on the Ethicon litigations, Mr. Grand is also a member of the Plaintiffs’ Steering Committees’ in several other federal proceedings that have been established in the U.S. District Court, Southern District of West Virginia for transvaginal mesh lawsuits filed against other medical device companies. These include American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and C.R. Bard, Inc., (MDL No. 2187); and Ethicon (MDL No. 2327).
Mr. Grand was also named Co-Liaison Counsel in a second litigation underway in Atlantic County Superior Court for lawsuits involving C.R. Bard products. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Women who allegedly suffered serious vaginal mesh complications following surgery to treat pelvic organ prolapse and stress urinary incontinence may be entitled to compensation from the company that manufactured the device. To learn more about the litigation involving transvaginal mesh lawsuits, please visit Bernstein Liebhard LLP, or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
*nj.com/business/index.ssf/2014/04/at_annual_meeting_johnson_johnson_execs_tout_advances_hear_patient_criticisms.html, Associated Press, April 25, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP